FEV1 (FORCED EXPIRATORY VOLUME IN THE 1ST SECOND) REVERSIBILITY AFTER NEBULISATION WITH SABA (SHORT ACTING BETA AGONIST) AS A MARKER OF CONTROL OF ASTHMA
-
Published:2023-01-01
Issue:
Volume:
Page:38-39
-
ISSN:
-
Container-title:INDIAN JOURNAL OF APPLIED RESEARCH
-
language:en
-
Short-container-title:IJAR
Author:
M Anjana.1, K Rugmini.2, P. Verghese Relve.1, k.e elizabeth.3
Affiliation:
1. Junior resident, Dept. Of Paediatrics, Sree Mookambika Institute of Medical Sciences 2. Paediatrician, Taluk Hospital, Fort, Thiruvananthapuram 3. Professor and HOD, Dept. of Paediatrics, Sree Mookambika Institute of Medical Sciences
Abstract
INTRODUCTION: Variable expiratory airow due to bronchoconstriction, airway wall thickening and increased
mucus is an obvious feature in asthma. Variable airow obstruction is evidenced by reversibility of FEV1 following a
bronchodilator inhalation. PFT (Pulmonary Function Testing) using spirometry is often used for the estimation of FEV1. Reversibility is not
uniform in all cases and vary with respect to severity and control of asthma.
AIMS & OBJECTIVES:
1) To determine the control of asthma in 5-15-year-old children using GINA checklist and estimate FEV1 before and after SABA nebulisation.
2) To nd out the association between FEV1 reversibility and control of asthma.
MATERIALS & METHODS: This cross-sectional study included 90 consecutive 5-15-year-old-children with a clinical diagnosis of asthma
attending the Paediatric OPD of a teaching hospital from October-May 2021. The symptoms, signs, comorbidities, treatment, compliance and
assessment of control of asthma into 2 subgroups: Well-controlled and Partly-controlled/Uncontrolled asthma, as per GINA 2020 were recorded.
All were subjected to spirometry for assessment of FEV1 before and 20 minutes after nebulisation with SABA. Depending upon FEV1, they
were grouped as those with >12% reversibility and <12% reversibility. Data analysed using SPSS 20.0, Paired t test for comparison of means,
Chi-square test for statistical difference in proportion, and post hoc tests. The RESULTS: M:F ratio was 1.2:1, 52.2% were 10-15 years and
47.8% 5-10 years. 68.9% had partly/uncontrolled, the rest well-controlled asthma (38.1%). The difference between mean FEV1 before
(67.9±10.6) and after nebulisation (80.6±9.7) was statistically signicant (p<0.00*). Among those with >12 reversibility, 64.5% were in
partly/uncontrolled and 35.5% in well-controlled asthma and the difference was statistically signicant (p -0.013*). The CONCLUSION:
nding in the study that 68.9% had partly/uncontrolled asthma is an eye-opener to optimise protocol-based treatment among children. The
statistically signicant difference of >12% before and after nebulisation a marker of poor control was observed in 64.5% of partly/uncontrolled
asthma compared to 35.5% of well controlled asthma. Hence, the persistence of a signicant degree of bronchodilator response noted in those
with partly/uncontrolled asthma is recommended as an objective surrogate of poor asthma control in children who can co-operate for a PFT in
order to optimise protocol-based treatment.
Publisher
World Wide Journals
Subject
Law,Cultural Studies,Demography,General Economics, Econometrics and Finance,Political Science and International Relations,Sociology and Political Science,Statistics, Probability and Uncertainty,Economics and Econometrics,Statistics and Probability,Plant Science,Aquatic Science,Economics and Econometrics,Finance,Management, Monitoring, Policy and Law,Ecology,Aquatic Science,Ecology, Evolution, Behavior and Systematics,General Medicine,Economics, Econometrics and Finance (miscellaneous),General Earth and Planetary Sciences,General Environmental Science,General Economics, Econometrics and Finance,Political Science and International Relations,Sociology and Political Science,History,Cultural Studies
Reference5 articles.
1. Global Initiative for Asthma (GINA) Global Strategy for Asthma Management and Prevention 2020. 2. Uppala R, Kaenpugdee P, Srisutthikamol S, Teeratakulpisarn J. Assessment of small airway function and reversibility in symptom-controlled asthma in pediatric patients. Asian Pac J Allergy Immunol. 2019 Mar;37(1):25-29. 3. Heffler E, Crimi C, Campisi R, Sichili S, Nicolosi G, Porto M, Intravaia R, Sberna ME, Liuzzo MT, Crimi N. Bronchodilator response as a marker of poor asthma control. Respir Med. 2016 Mar; 112:45-50. 4. Wei J, Ma L, et al. Airway reversibility in asthma and phenotypes of Th2 biomarkers, lung function and disease control; Allergy Asthma Clin Immunology (2018) 14:89 5. Busse WW, Holgate ST, Wenzel SW, Klekotka P, Chon Y, Feng J, et al. Biomarker profiles in asthma with high vs low airway reversibility and poor disease control. Chest. 2015;148(6):1489–1496.
|
|